13,14,000 Equity shares allotted pursuant to conversion of fully paid warrants.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd has allotted 13,14,000 equity shares after some warrant holders chose to convert their warrants into shares. These warrants were originally issued on August 6, 2025 as part of a preferential allotment of 88,08,000 warrants at ₹42.25 each (₹10 face value + ₹32.25 premium). The company received the remaining 75% exercise price of ₹31.6875 per warrant, totalling about ₹4.16 crore in fresh capital from 14 non-promoter investors. As a result, the company's paid-up equity share capital has increased from ₹11.56 crore (1.15 crore shares) to ₹12.87 crore (1.29 crore shares). About 24,09,000 warrants still remain unconverted from the original issue.
This is a positive development as the company has successfully raised an additional ₹4.16 crore from warrant conversions, strengthening its capital base. The dilution from these conversions is modest and the shares will rank equally with existing shares, which may apply mild downward pressure on the stock price in the short term.